ES8601108A1 - Procedimiento para la obtencion de eglinas b o c modificadas - Google Patents

Procedimiento para la obtencion de eglinas b o c modificadas

Info

Publication number
ES8601108A1
ES8601108A1 ES534098A ES534098A ES8601108A1 ES 8601108 A1 ES8601108 A1 ES 8601108A1 ES 534098 A ES534098 A ES 534098A ES 534098 A ES534098 A ES 534098A ES 8601108 A1 ES8601108 A1 ES 8601108A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
proteinase inhibitors
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534098A
Other languages
English (en)
Spanish (es)
Other versions
ES534098A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES534098A0 publication Critical patent/ES534098A0/es
Publication of ES8601108A1 publication Critical patent/ES8601108A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
  • Pyrrole Compounds (AREA)
ES534098A 1983-07-07 1984-07-06 Procedimiento para la obtencion de eglinas b o c modificadas Expired ES8601108A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3324534A DE3324534A1 (de) 1983-07-07 1983-07-07 Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel

Publications (2)

Publication Number Publication Date
ES534098A0 ES534098A0 (es) 1985-10-16
ES8601108A1 true ES8601108A1 (es) 1985-10-16

Family

ID=6203414

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534098A Expired ES8601108A1 (es) 1983-07-07 1984-07-06 Procedimiento para la obtencion de eglinas b o c modificadas

Country Status (10)

Country Link
US (1) US4636489A (en, 2012)
EP (1) EP0134479B1 (en, 2012)
JP (1) JPH0670077B2 (en, 2012)
AT (1) ATE32728T1 (en, 2012)
CA (1) CA1230069A (en, 2012)
DE (2) DE3324534A1 (en, 2012)
DK (1) DK165988C (en, 2012)
ES (1) ES8601108A1 (en, 2012)
GR (1) GR82243B (en, 2012)
IE (1) IE57698B1 (en, 2012)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342373B1 (en) * 1983-11-21 2002-01-29 Ucp Gen-Pharma Ag Process for preparing recombinant eglin, protease inhibitor
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
US5180667A (en) * 1988-03-07 1993-01-19 Ciba-Geigy Corporation Genes encoding eglin C mutants
ES2063161T3 (es) * 1988-03-07 1995-01-01 Ciba Geigy Ag Proteinas modificadas.
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
FI905825A0 (fi) * 1988-05-27 1990-11-26 Magainin Sciences Inc Amfifiliska peptider och deras anvaendning.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
WO1991012015A1 (en) * 1990-02-08 1991-08-22 Magainin Sciences Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
WO1992020357A1 (en) * 1991-05-23 1992-11-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
AU2901692A (en) * 1991-10-16 1993-05-21 Children's Hospital Of Philadelphia, The Composition and treatment with biologically active peptides and antibiotic
ATE206055T1 (de) * 1994-06-02 2001-10-15 Merrell Pharma Inc Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
CN1152048C (zh) * 1994-06-02 2004-06-02 默里尔药物公司 弹性蛋白酶的全氟烷基酮抑制剂及其制备方法
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
DK0929577T3 (da) 1996-09-24 2003-10-06 Procter & Gamble Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
US7001884B2 (en) * 2001-06-18 2006-02-21 Regents Of The University Of Michigan Eglin c based drugs for treatment of disease
DE102005007313A1 (de) * 2005-02-17 2006-08-24 Wacker Chemie Ag Verfahren zur Herstellung von Entschäumerformulierungen
KR101237116B1 (ko) * 2010-11-12 2013-02-25 대한유화공업 주식회사 내충격성 및 내압특성이 우수한 폴리프로필렌 조성물
CN110551707A (zh) * 2019-10-17 2019-12-10 山西大学 一种纯化中性或碱性蛋白酶的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808396C2 (de) * 1978-02-27 1984-04-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Protease-Inhibitoren
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2

Also Published As

Publication number Publication date
ES534098A0 (es) 1985-10-16
JPS60105699A (ja) 1985-06-11
DE3469534D1 (en) 1988-04-07
DE3324534A1 (de) 1985-01-17
DK332684A (da) 1985-01-08
JPH0670077B2 (ja) 1994-09-07
GR82243B (en, 2012) 1984-12-13
EP0134479B1 (de) 1988-03-02
DK165988B (da) 1993-02-22
IE841734L (en) 1985-01-07
EP0134479A1 (de) 1985-03-20
DK332684D0 (da) 1984-07-06
CA1230069A (en) 1987-12-08
DK165988C (da) 1993-07-26
US4636489A (en) 1987-01-13
ATE32728T1 (de) 1988-03-15
IE57698B1 (en) 1993-03-10

Similar Documents

Publication Publication Date Title
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
DK250181A (da) Fremgangsmaade til fremstilling af vinblastinderivater
ES2103305T3 (es) Produccion de inhibidor de interleuquina-1 humana recombinada.
DK304682A (da) Vandholdigt topisk praeparat og fremgangsmaade til formindskelse af vandtab fra saadanne praeparater
IL75637A (en) Thymopentin analogs and pharmaceutical compositions containing them
PT73291A (en) Process for the preparation of novel peptides
ES548052A0 (es) Procedimiento para preparar peptidos
ES8704511A1 (es) Procedimiento para sintetizar peptidos a partir de aminoaci-dos
DE3160757D1 (en) Amino acid and peptide esters of leuco-indo anilines, process for their preparation and agents containing these compounds for the detection of proteolytic enzymes
NZ210267A (en) Expression vectors for eglin b or c (protease inhibitors), transformed host, preparation, modified eglins and compositions
DE3371076D1 (en) Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them
EP0213474A3 (en) Substituted toluidines, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FI891020A0 (fi) Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
FI853354A7 (fi) Aminohappojohdokset, menetelmä niiden valmistamiseksi ja farmaseuttiset seokset.
SE8203054L (sv) Antihypertensivt medel
AR244241A1 (es) Procedimiento para preparar derivados de acido n-(aminoalcanoil)-azabiciclocarboxilico
FI810866A7 (fi) Substituoituja alkyylitioasyyliaminohappoja, niiden valmistusmenetelmiä ja farmaseuttfarmaseuttisia seoksia.
SE8304972D0 (sv) Piperidinylcyklopentanolheptensyrasalt
MX167915B (es) Procedimiento para preprar una composicion farmaceutica para el tratamiento de excitacion psicomotriz
IT8323052A0 (it) N-(2-mercaptopropionil)glicina, derivati della procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401